Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
67,492,943
-
Shares change
-
-1,721,967
-
Total reported value, excl. options
-
$3,609,431,770
-
Value change
-
-$76,258,753
-
Put/Call ratio
-
61.83%
-
Number of buys
-
105
-
Number of sells
-
-86
-
Price
-
$53.48
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2020
258 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q2 2020.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,492,943 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7,866,877 shares), VANGUARD GROUP INC (5,744,910 shares), FMR LLC (5,616,327 shares), BlackRock Inc. (5,006,831 shares), Bellevue Group AG (4,023,573 shares), Capital International Investors (3,854,832 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,277,313 shares), GOLDMAN SACHS GROUP INC (1,993,663 shares), STATE STREET CORP (1,894,628 shares), and ORBIMED ADVISORS LLC (1,728,421 shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.